These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 6779101)

  • 21. Anti-PcrV antibody strategies against virulent Pseudomonas aeruginosa.
    Sawa T; Ito E; Nguyen VH; Haight M
    Hum Vaccin Immunother; 2014; 10(10):2843-52. PubMed ID: 25483637
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serologic and protective cross-reactivity of antisera to Pseudomonas aeruginosa extracellular slime glycolipoprotein.
    Yushkova NA; Kholodkova EV; Korobova TS; Stanislavsky ES
    Acta Microbiol Hung; 1986; 33(2):147-56. PubMed ID: 3101393
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Depletion of natural killer cells increases mice susceptibility in a Pseudomonas aeruginosa pneumonia model.
    Broquet A; Roquilly A; Jacqueline C; Potel G; Caillon J; Asehnoune K
    Crit Care Med; 2014 Jun; 42(6):e441-50. PubMed ID: 24732238
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antibody response of infected mice to outer membrane proteins of Pseudomonas aeruginosa.
    Hedstrom RC; Pavlovskis OR; Galloway DR
    Infect Immun; 1984 Jan; 43(1):49-53. PubMed ID: 6418663
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Dynamics of humoral antibody formation against the O-antigen of Pseudomonas aeruginosa in suppurative diseases].
    Zarubina EK; Svetukhin AM; Edvabnaia LS
    Khirurgiia (Mosk); 1980 Nov; (11):47-52. PubMed ID: 6777579
    [No Abstract]   [Full Text] [Related]  

  • 26. Protective effects of affinity-purified antibody and truncated vaccines against Pseudomonas aeruginosa V-antigen in neutropenic mice.
    Moriyama K; Wiener-Kronish JP; Sawa T
    Microbiol Immunol; 2009 Nov; 53(11):587-94. PubMed ID: 19903258
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Delayed-type hypersensitivity to allogeneic mouse epidermal cell antigens. I. Lyt-1+2- T cells are important for DTH.
    Ishii N; Nakajima H; Aoki I; Ishii T; Takahashi T; Okuda K
    Immunogenetics; 1986; 23(6):351-6. PubMed ID: 3721540
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A lack of correlation between antigen-specific cellular reactions and resistance to Mycobacterium lepraemurium infection in mice.
    Curtis J; Adu HO; Turk JL
    Immunology; 1981 Jun; 43(2):293-301. PubMed ID: 7019051
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pseudomonas aeruginosa infection and vaccination in the rat.
    Kostiala AA
    J Med Microbiol; 1980 May; 13(2):201-12. PubMed ID: 6770090
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antibody response to Pseudomonas aeruginosa surface protein antigens in a rat model of chronic lung infection.
    Cochrane DM; Brown MR; Anwar H; Weller PH; Lam K; Costerton JW
    J Med Microbiol; 1988 Dec; 27(4):255-61. PubMed ID: 3143837
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Live
    Aguilera-Herce J; García-Quintanilla M; Romero-Flores R; McConnell MJ; Ramos-Morales F
    mSphere; 2019 Apr; 4(2):. PubMed ID: 30996108
    [No Abstract]   [Full Text] [Related]  

  • 32. Common protective antigen between Pseudomanas aeruginosa and Vibrio cholerae.
    Yamamoto A; Homma JY; Ghoda A; Ishihara T; Takeuchi S
    Jpn J Exp Med; 1979 Dec; 49(6):383-90. PubMed ID: 120454
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pseudomonas aeruginosa infection depresses contact sensitivity to oxazolone by enhancing suppressor cell activity.
    Colizzi V; Campa M; Garzelli C; Falcone G
    Med Microbiol Immunol; 1979 Aug; 167(3):181-8. PubMed ID: 158702
    [TBL] [Abstract][Full Text] [Related]  

  • 34. T lymphocyte-mediated protection against Pseudomonas aeruginosa infection in granulocytopenic mice.
    Powderly WG; Pier GB; Markham RB
    J Clin Invest; 1986 Aug; 78(2):375-80. PubMed ID: 2426306
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Investigation on the protection of mice from infection with Pseudomonas aeruginosa using monoclonal antibodies].
    Ye DN; Wang CX; Yan RH; Dai BM; Ni HY
    Sichuan Yi Xue Yuan Xue Bao; 1985 Sep; 16(3):188-90. PubMed ID: 3939267
    [No Abstract]   [Full Text] [Related]  

  • 36. Development of an anti-adhesive vaccine for Pseudomonas aeruginosa targeting the C-terminal region of the pilin structural protein.
    Sheth HB; Glasier LM; Ellert NW; Cachia P; Kohn W; Lee KK; Paranchych W; Hodges RS; Irvin RT
    Biomed Pept Proteins Nucleic Acids; 1995; 1(3):141-8. PubMed ID: 9346845
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The genetic effect of engineered vaccine on Pseudomonas aeruginosa infection in mice.
    Nishio M; Isobe Y; Hatano H; Ohno S; Okuda K; Ishii N
    Immunogenetics; 1993; 38(4):280-2. PubMed ID: 8319977
    [No Abstract]   [Full Text] [Related]  

  • 38. Antigen-specific augmentation factor involved in murine delayed-type footpad reaction. II. Augmentation of delayed-type footpad reaction and acquired resistance to Listeria monocytogenes by transfer of Listeria-immune serum.
    Himeno K; Yamada A; Kawakita T; Nakamura S; Mitsuyama M; Nomoto K
    Med Microbiol Immunol; 1987; 176(5):229-39. PubMed ID: 2443824
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of Pseudomonas aeruginosa lipopolysaccharide on phytohaemagglutinin induced lymphocyte transformation.
    Gallyas A; Petrás G; Adám MM; Merétey K
    Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1981 Nov; 250(4):497-505. PubMed ID: 6800150
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Activation of pulmonary and lymph node dendritic cells during chronic Pseudomonas aeruginosa lung infection in mice.
    Damlund DS; Christophersen L; Jensen PØ; Alhede M; Høiby N; Moser C
    APMIS; 2016 Jun; 124(6):500-7. PubMed ID: 27009697
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.